John M Capek - EXECUTIVE VICE PRESIDENT, Abbott Laboratories

As of March 2, 2022


What is John M Capek's Net Worth?

The current estimated net worth of Abbott Laboratories's EXECUTIVE VICE PRESIDENT, John M Capek, is estimated to be about $90.65M . John M Capek owns about 321,398 units of Abbott Laboratories common stock. In the last 15 years at Abbott Laboratories, John M Capek has sold an estimated value of $62.67M worth.

What is John M Capek's Past Insider Trading?

John M Capek's largest purchase order was 149,600 units , worth over $5.23M on December 15, 2021. John M Capek's largest sale order was 149,600 units , worth over $20.2M on December 15, 2021. In total, John M Capek has made about 45 transactions over 15 years of their time at Abbott Laboratories. John M Capek usually trades in February, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was John M Capek's Salary in 2020?

As EXECUTIVE VICE PRESIDENT of Abbott Laboratories, John M Capek has a total base salary of $ . The vast majority of their compensation came in the form of salary of $ , stock awards of $ , option awards of $ , other earnings, plans or compensations of $ , change in pension value of $ , other compensation of $ , and other earnings, plans or compensations of $ .

What is John M Capek's' Mailing Address?

  • Mailing address is 111 Monument Circle, Suite 2900 Indianapolis IN 46204-5129 IN

Abbott Laboratories Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Other Earnings Plans or Compensations
Change in Pension Value
Robert B. Ford, 2020 $20,450,586 $1,298,462 $5,623,995 $5,624,993 $20,450,586 $16,549,550 $77,872 $20,450,586 $16,549,550
Robert B. Ford, 2019 $11,897,886 $1,000,000 $3,475,992 $3,476,054 $11,897,886 $9,777,514 $71,841 $11,897,886 $9,777,514
Robert B. Ford, 2018 $8,127,252 $784,250 $2,691,621 $2,691,897 $8,127,252 $7,821,493 $279,213 $8,127,252 $7,821,493
Robert E. Funck, Jr., 2020 $ $ $ $ $ $ $ $ $
Hubert L. Allen, 2020 $8,478,177 $751,346 $1,874,607 $1,874,988 $8,478,177 $5,919,894 $154,596 $8,478,177 $5,919,894
Hubert L. Allen, 2019 $7,486,080 $710,000 $2,199,962 $2,199,990 $7,486,080 $6,386,933 $66,905 $7,486,080 $6,386,933
Hubert L. Allen, 2018 $7,317,776 $706,709 $2,691,621 $2,691,897 $7,317,776 $7,278,480 $120,316 $7,317,776 $7,278,480
John F. Ginascol, 2020 $ $ $ $ $ $ $ $ $
Daniel G. Salvadori, 2020 $5,975,739 $710,000 $1,901,708 $1,902,099 $5,975,739 $5,518,569 $79,421 $5,975,739 $5,518,569
Daniel G. Salvadori, 2019 $6,767,814 $704,923 $2,351,989 $2,351,986 $6,767,814 $6,388,821 $59,806 $6,767,814 $6,388,821
Daniel G. Salvadori, 2018 $5,954,210 $675,038 $1,993,798 $1,993,992 $5,954,210 $5,907,979 $434,514 $5,954,210 $5,907,979
Miles D. White, 2020 $ $ $ $ $ $ $ $ $
Miles D. White, 2019 $ $ $ $ $ $ $ $ $
Miles D. White, 2018 $ $ $ $ $ $ $ $ $
Brian B. Yoor, 2020 $3,489,479 $207,837 $1,231,027 $1,231,237 $3,489,479 $2,839,222 $38,264 $3,489,479 $2,839,222
Brian B. Yoor, 2019 $9,015,698 $825,000 $2,449,976 $2,449,987 $9,015,698 $7,031,097 $71,331 $9,015,698 $7,031,097
Brian B. Yoor, 2018 $7,612,836 $796,057 $2,691,621 $2,691,897 $7,612,836 $7,280,548 $73,483 $7,612,836 $7,280,548
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1800/000104746921000592/a2242988zdef14a.htm

What are Abbott Laboratories's Past Insider Trades?

Abbott Laboratories's most recent insider trade came on May 5, 2022 by Randel William Woodgrift who sold 24,000 units worth $2.71M . In the last 19 years, insiders at Abbott Laboratories have sold an estimated value of $1.74B and bought an estimated value of $1.14B worth of shares. Insider trading is most common in February, with the busiest year in 2009. The most active traders at the company are Miles D White, EXECUTIVE CHAIRMAN,  Stephen R Fussell, Executive Vice President,  and Robert J Alpern .

ABBOTT LABORATORIES Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1